Friday, January 14, 2022 4:24:50 PM
flipper44,
I think that is soon but I also believe the priority has been to get Flaskworks into service ASAP and I assume this is with help from Dr Ashkan and Charles Rivers Labs readiness/training. In my mind nobody seriously involved in this process wants patients to hear about something they see as a major breakthrough but can’t access really soon. Think back to that German doctor telling the wife of a GBM patient that L would not be available until 2020. Now multiply that out by 10s of thousands and more once news hits. I just pray this timing works out for the sake of all the patients and their families and that reimbursement can be worked out quickly. Dr Linda Liau received her MBA based on her studies in this area. Best wishes.
I think that is soon but I also believe the priority has been to get Flaskworks into service ASAP and I assume this is with help from Dr Ashkan and Charles Rivers Labs readiness/training. In my mind nobody seriously involved in this process wants patients to hear about something they see as a major breakthrough but can’t access really soon. Think back to that German doctor telling the wife of a GBM patient that L would not be available until 2020. Now multiply that out by 10s of thousands and more once news hits. I just pray this timing works out for the sake of all the patients and their families and that reimbursement can be worked out quickly. Dr Linda Liau received her MBA based on her studies in this area. Best wishes.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
